miR-21/PDCD4/AP-1对食管癌细胞增殖、侵袭及迁移的影响(5)
[14] Fassan M，Pizzi M，Battaglia G，et al. Programmed cell death 4 (PDCD4) expression during multistep Barrett′s carcinogenesis [J]. J Clin Pathol，2010，63(8)：692-696.
[15] 張建东，贺利民，马磊，等.miR-21、PDCD4表达对Ⅱ期食管鳞癌术后患者生存期的影响[J].肿瘤学杂志，2017， 183(12)：5-12.
[16] Zhang J，Ma L，Shi D，et al. Prognostic significance of miR-21 and PDCD4 in patients with stage Ⅱ esophageal carcinoma after surgical resection [J]. J Cell Biochem，2018，119(6)：4783-4791.
[17] 虞勇，虞莹，刘桂剑，等.miR21对心脏微血管内皮细胞PDCD4/AP1通路的调节作用[J].中国分子心脏病学杂志，2015，15(6)：1534-1538.
[18] Zhu Q，Wang Z，Hu Y，et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma [J]. Oncol Rep，2012，27(5)：11660-11668.
[19] Chang CR，Wang HY，Liu JC，et al. Porphyromonas gingivalis infection promoted the proliferation of oral squamous cell carcinoma cells through the miR-21/PDCD4/AP-1 negative signaling pathway [J]. ACS Infect Dis，2019，5(8)：1336-1347.
[20] Talotta F，Cimmino A，Matarazzo MR，et al. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation [J]. Oncogene，2009，28(1)：73-84.
(收稿日期：2020-02-28), 百拇医药(杨鲸蓉 吴健 叶仕新)
[15] 張建东，贺利民，马磊，等.miR-21、PDCD4表达对Ⅱ期食管鳞癌术后患者生存期的影响[J].肿瘤学杂志，2017， 183(12)：5-12.
[16] Zhang J，Ma L，Shi D，et al. Prognostic significance of miR-21 and PDCD4 in patients with stage Ⅱ esophageal carcinoma after surgical resection [J]. J Cell Biochem，2018，119(6)：4783-4791.
[17] 虞勇，虞莹，刘桂剑，等.miR21对心脏微血管内皮细胞PDCD4/AP1通路的调节作用[J].中国分子心脏病学杂志，2015，15(6)：1534-1538.
[18] Zhu Q，Wang Z，Hu Y，et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma [J]. Oncol Rep，2012，27(5)：11660-11668.
[19] Chang CR，Wang HY，Liu JC，et al. Porphyromonas gingivalis infection promoted the proliferation of oral squamous cell carcinoma cells through the miR-21/PDCD4/AP-1 negative signaling pathway [J]. ACS Infect Dis，2019，5(8)：1336-1347.
[20] Talotta F，Cimmino A，Matarazzo MR，et al. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation [J]. Oncogene，2009，28(1)：73-84.
(收稿日期：2020-02-28), 百拇医药(杨鲸蓉 吴健 叶仕新)